Jonathan P. Schneck
Affiliations: | Johns Hopkins University, Baltimore, MD |
Area:
Immunology, General BiophysicsWebsite:
https://www.hopkinsmedicine.org/profiles/details/jonathan-schneckGoogle:
"Jonathan Schneck"Bio:
https://hdl.handle.net/20.500.12202/2857
Mean distance: (not calculated yet)
Children
Sign in to add trainee| Kapil Gupta | grad student | 2007 | Johns Hopkins |
| Yen-Ling Chiu | grad student | 2013 | Johns Hopkins |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Omotoso MO, Lanis MR, Schneck JP. (2024) Artificial Antigen-Presenting Cell Fabrication for Murine T Cell Expansion. Current Protocols. 4: e976 |
| Livingston NK, Hickey JW, Sim H, et al. (2024) In Vivo Stimulation of Therapeutic Antigen-Specific T Cells in an Artificial Lymph Node Matrix. Advanced Materials (Deerfield Beach, Fla.). e2310043 |
| Zhu Y, Ma J, Shen R, et al. (2023) Screening for lipid nanoparticles that modulate the immune activity of helper T cells towards enhanced antitumour activity. Nature Biomedical Engineering |
| Ben-Akiva E, Hickey JW, Meyer RA, et al. (2023) Shape Matters: Biodegradable Anisotropic Nanoparticle Artificial Antigen Presenting Cells for Cancer Immunotherapy. Acta Biomaterialia |
| Lu J, Chen G, Sorokina A, et al. (2022) Cytomegalovirus infection reduced CD70 expression, signaling and expansion of viral specific memory CD8 T cells in healthy human adults. Immunity & Ageing : I & A. 19: 54 |
| Isser A, Silver AB, Pruitt HC, et al. (2022) Nanoparticle-based modulation of CD4 T cell effector and helper functions enhances adoptive immunotherapy. Nature Communications. 13: 6086 |
| Chaisawangwong W, Wang H, Kouo T, et al. (2022) Cross-reactivity of SARS-CoV-2- and influenza A-specific T cells in individuals exposed to SARS-CoV-2. Jci Insight. 7 |
| Sung BY, Lin YH, Kong Q, et al. (2022) Wnt activation promotes memory T cell polyfunctionality via epigenetic regulator PRMT1. The Journal of Clinical Investigation. 132 |
| Est-Witte SE, Livingston NK, Omotoso MO, et al. (2021) Nanoparticles for generating antigen-specific T cells for immunotherapy. Seminars in Immunology. 56: 101541 |
| Rhodes KR, Isser A, Hickey JW, et al. (2021) Biodegradable Cationic Polymer Blends for Fabrication of Enhanced Artificial Antigen Presenting Cells to Treat Melanoma. Acs Applied Materials & Interfaces |